Larimar Therapeutics Inc (ZA71)

Frankfurt
Currency in EUR
2.060
+0.120(+6.19%)
Closed·
ZA71 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
2.0602.060
52 wk Range
1.5009.600
Key Statistics
Edit
Bid/Ask
2.04 / 2.06
Prev. Close
1.94
Open
2.06
Day's Range
2.06-2.06
52 wk Range
1.5-9.6
Volume
-
Average Volume (3m)
604
1-Year Change
-64.48%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ZA71 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Larimar Therapeutics Inc Company Profile

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich’s ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Compare ZA71 to Peers and Sector

Metrics to compare
ZA71
Peers
Sector
Relationship
P/E Ratio
−1.9x−2.8x−0.5x
PEG Ratio
0.030.010.00
Price/Book
0.9x1.6x2.6x
Price / LTM Sales
-11.2x2.9x
Upside (Analyst Target)
-316.7%60.5%
Fair Value Upside
Unlock6.4%8.5%Unlock

Earnings

Latest Release
Mar 24, 2025
EPS / Forecast
-0.45 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

19.00
IDYA
-0.37%
3.830
OB
+0.79%
28.34
FORM
+0.46%
6.500
SIGA
+0.31%

FAQ

What Is the Larimar Therapeutics Inc (ZA71) Stock Price Today?

The Larimar Therapeutics Inc stock price today is 2.06

What Stock Exchange Does Larimar Therapeutics Inc Trade On?

Larimar Therapeutics Inc is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Larimar Therapeutics Inc?

The stock symbol for Larimar Therapeutics Inc is "ZA71."

What Is the Larimar Therapeutics Inc Market Cap?

As of today, Larimar Therapeutics Inc market cap is 131.25M.

What is Larimar Therapeutics Inc Earnings Per Share?

The Larimar Therapeutics Inc EPS is -1.32.

From a Technical Analysis Perspective, Is ZA71 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.